Atherosclerosis Etiology Trial in Ehime

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: Telmisartan six month 80mg once a day Amlodipine six month 5mg once a day CONDITION: Ischemic Heart Disease PRIMARY OUTCOME: Gene expression analysis(DNA array QRT‐PCR) of total RNA from human monocyte.; Measurement of serum adipokines and cytokines. INCLUSION CRITERIA: Inpatient with acute myocardial infarction or angina pectoris who needs treatment of catheter intervention. And treatment of hypertension.
Epistemonikos ID: e7679b16dc1172b23dee1f16e4a6ea006f621170
First added on: Aug 22, 2024